Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00148304 · ClinicalTrials.gov registry record

Insulin Treatment Variation in Southwestern Diabetics

A clinical trial of Diabetes and Self-Monitoring, Blood Glucose, sponsored by VA Office of Research and Development.

Completed
Registry status
1,248
Enrollment target
3
Study locations

NCT00148304 is a study of Diabetes and Self-Monitoring, Blood Glucose that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,248 participants, below the 3,025-participant average among 338 other Diabetes trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00148304, a study of Diabetes and Self-Monitoring, Blood Glucose, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
1,248 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to better understand disparities in insulin dosing, hemoglobin A1c, and self-reported patient self-care behaviors among non-Hispanic white, Hispanic, and African American veterans with type 2 diabetes receiving VA care.

Study Locations (3)

Arizona

  • Phoenix VA Health Care System, Phoenix, AZ - Phoenix
  • Southern Arizona VA Health Care System, Tucson, AZ - Tucson

New Mexico

  • New Mexico VA Health Care System, Albuquerque, NM - Albuquerque

Trial Details

FieldValue
Enrollment Target 1,248 participants
Start Date 2005-09
Est. Completion 2008-06

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00148304

The ClinicalTrials.gov registry entry for NCT00148304 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,248 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,025-participant average among 338 other Diabetes trials with a reported enrollment target (59% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT00148304 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Arizona, New Mexico.

Frequently Asked Questions

What is clinical trial NCT00148304 about?

NCT00148304 is a clinical study titled "Insulin Treatment Variation in Southwestern Diabetics". The purpose of this study is to better understand disparities in insulin dosing, hemoglobin A1c, and self-reported patient self-care behaviors among non-Hispanic white, Hispanic, and African American veterans with type 2 diabetes receiving VA care.

What is the current status of trial NCT00148304?

This trial is currently completed. The enrollment target is 1,248 participants. The study started on 2005-09. Estimated completion is 2008-06.

What conditions does trial NCT00148304 study?

This clinical trial studies the following conditions: Diabetes, Self-Monitoring, Blood Glucose.

Who is sponsoring clinical trial NCT00148304?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00148304 being conducted?

This trial has 3 study locations across Arizona, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.